Predicted Coronary Heart Disease Risk Reduction and Dual Blood Pressure/Cholesterol Goal Attainment in Patients With Hypertension Treated in Real‐World Clinical Practice

J Clin Hypertens (Greenwich). 2010;12:396–406. ©2010 Wiley Periodicals, Inc. Hypertension and dyslipidemia are highly co‐prevalent, but often poorly controlled, coronary heart disease (CHD) risk factors. A retrospective cohort study was conducted between January 2004 and April 2008 to compare estima...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2010-06, Vol.12 (6), p.396-406
Hauptverfasser:	Neutel, Joel M., Eaddy, Michael, Lunacsek, Orsolya E., Roberts, Craig, Chen, Linda, Kean, Allison J., Jackson, James H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amlodipine - therapeutic use Anticholesteremic Agents - therapeutic use Antihypertensive Agents - therapeutic use Atorvastatin Blood Pressure Calcium Channel Blockers - therapeutic use Cholesterol, LDL Cohort Studies Coronary Artery Disease - prevention & control Databases, Factual Drug Therapy, Combination Female Health Records, Personal Heptanoic Acids - therapeutic use Humans Hyperlipidemias - drug therapy Hypertension - drug therapy Male Middle Aged Original Papers Prognosis Pyrroles - therapeutic use Retrospective Studies Risk Risk Factors Risk Reduction Behavior
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!